Amrize (NYSE:AMRZ) Sets New 1-Year Low – What’s Next?

Shares of Amrize Ltd (NYSE:AMRZ) reached a new 52-week low on Wednesday. The stock traded as low as $36.46 and last traded at $36.4760, with a volume of 552601 shares traded. The stock had previously closed at $37.28.

Wall Street Analysts Forecast Growth

AMRZ has been the subject of several research analyst reports. Oppenheimer dropped their target price on shares of Amrize from $62.00 to $55.00 and set an “outperform” rating for the company in a research report on Friday, September 18th. JPMorgan Chase & Co. downgraded shares of Amrize from an “overweight” rating to a “neutral” rating and dropped their price objective for the stock from $57.00 to $52.00 in a report on Wednesday, September 2nd. Truist Financial lowered their price target on Amrize from $48.00 to $35.00 and set a “hold” rating on the stock in a research report on Monday. Royal Bank Of Canada cut Amrize from a “sector perform” rating to an “underperform” rating and decreased their price objective for the company from $60.00 to $48.00 in a report on Monday, August 10th. Finally, Wells Fargo & Company lowered their price objective on shares of Amrize from $44.00 to $40.00 and set an “equal weight” rating for the company in a report on Monday. One analyst has rated the stock with a Strong Buy rating, seven have assigned a Buy rating, eight have issued a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $51.76.

Amrize Stock Up 0.2%

The company’s fifty day simple moving average is $42.59 and its 200 day simple moving average is $49.57. The company has a current ratio of 1.10, a quick ratio of 0.73 and a debt-to-equity ratio of 0.33. The firm has a market capitalization of $20.17 billion, a P/E ratio of 16.80, a price-to-earnings-growth ratio of 1.28 and a beta of 0.20.

Amrize (NYSE:AMRZ) last posted its quarterly earnings data on Thursday, August 6th. The company reported $0.88 earnings per share for the quarter, missing the consensus estimate of $0.92 by ($0.04). The firm had revenue of $3.49 billion for the quarter. Amrize had a net margin of 9.89% and a return on equity of 10.22%. Research analysts expect that Amrize Ltd will post 2.46 EPS for the current year.

Amrize Announces Dividend

The company also recently disclosed a dividend, which was paid on Wednesday, August 26th. Investors of record on Tuesday, August 18th were issued a $0.11 dividend. The ex-dividend date was Tuesday, August 18th. Amrize’s payout ratio is presently 20.28%.

Insider Transactions at Amrize

In other Amrize news, CEO Jan Jenisch bought 26,000 shares of the firm’s stock in a transaction on Wednesday, September 2nd. The stock was acquired at an average price of $42.47 per share, with a total value of $1,104,220.00. Following the transaction, the chief executive officer owned 1,767,000 shares in the company, valued at $75,044,490. This represents a 1.49% increase in their ownership of the stock. The acquisition was disclosed in a filing with the SEC, which is accessible through this link. Also, insider Mario Gross acquired 3,568 shares of the firm’s stock in a transaction dated Tuesday, August 11th. The shares were bought at an average cost of $46.60 per share, with a total value of $166,268.80. Following the completion of the acquisition, the insider directly owned 38,485 shares of the company’s stock, valued at $1,793,401. The trade was a 10.22% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Over the last ninety days, insiders have bought 48,983 shares of company stock valued at $2,158,755. Insiders own 0.54% of the company’s stock.

Institutional Trading of Amrize

A number of hedge funds and other institutional investors have recently bought and sold shares of the stock. Caldwell Sutter Capital Inc. boosted its position in shares of Amrize by 11.5% during the 1st quarter. Caldwell Sutter Capital Inc. now owns 2,675 shares of the company’s stock worth $150,000 after purchasing an additional 275 shares in the last quarter. Grove Bank & Trust boosted its holdings in Amrize by 2.1% during the third quarter. Grove Bank & Trust now owns 17,477 shares of the company’s stock worth $653,000 after buying an additional 353 shares in the last quarter. Baldwin Investment Management LLC grew its position in Amrize by 4.4% during the fourth quarter. Baldwin Investment Management LLC now owns 8,980 shares of the company’s stock worth $486,000 after buying an additional 375 shares during the period. Mengis Capital Management Inc. increased its holdings in Amrize by 8.5% in the fourth quarter. Mengis Capital Management Inc. now owns 5,750 shares of the company’s stock valued at $311,000 after buying an additional 450 shares in the last quarter. Finally, Norman Fields Gottscho Capital Management LLC lifted its position in shares of Amrize by 4.3% during the 2nd quarter. Norman Fields Gottscho Capital Management LLC now owns 11,515 shares of the company’s stock valued at $614,000 after acquiring an additional 475 shares during the period.

About Amrize

Amrize Ltd. is a North American building solutions company that produces and supplies essential construction materials and related products. Its portfolio includes cement, aggregates, ready-mix concrete, asphalt, concrete products and roofing systems used in residential, commercial and infrastructure projects.

The company serves customers across the United States and Canada through a network of production facilities, distribution locations and other operating sites. Its products support a range of construction applications, including roads, bridges, buildings, homes and other major infrastructure.

Amrize was established as the result of the separation of Holcim’s North American business and began operating as an independent, publicly traded company in 2025.